NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
The tumor microenvironment (TME) in pancreatic ductal adenocarcinoma (PDA) is characterized by immune tolerance, which enables disease to progress unabated by adaptive immunity. However, the drivers of this tolerogenic program are incompletely defined. In this study, we found that NLRP3 promotes expansion of immune-suppressive macrophages in PDA. NLRP3 signaling in macrophages drives the differentiation of CD4+ T cells into tumor-promoting T helper type 2 cell (Th2 cell), Th17 cell, and regulatory T cell populations while suppressing Th1 cell polarization and cytotoxic CD8+ T cell activation. The suppressive effects of NLRP3 signaling were IL-10 dependent. Pharmacological inhibition or deletion of NLRP3, ASC (apoptosis-associated speck-like protein containing a CARD complex), or caspase-1 protected against PDA and was associated with immunogenic reprogramming of innate and adaptive immunity within the TME. Similarly, transfer of PDA-entrained macrophages or T cells from NLRP3−/− hosts was protective. These data suggest that targeting NLRP3 holds the promise for the immunotherapy of PDA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In those cases, IL-1β is the key player, acting as pro-inflammatory, tumor-promoting trigger [126,127,128,129,130].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [130]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1256 · Cited by 3,367
Activation and regulation of the inflammasomes
Latz, E., Xiao, T. S., & Stutz, A. (2013) · Nature Reviews Immunology · doi:10.1038/nri3452 · Cited by 2,884
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
Vandanmagsar, B., Youm, Y.-H., Ravussin, A., Galgani, J. E., Stadler, K., Mynatt, R. L., Ravussin, E., Stephens, J. M., & Dixit, V. D. (2011) · Nature Medicine · doi:10.1038/nm.2279 · Cited by 2,655
Hingorani, S. R., Wang, L., Multani, A. S., Combs, C., Deramaudt, T. B., Hruban, R. H., Rustgi, A. K., Chang, S., & Tuveson, D. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.023 · Cited by 2,609
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
Hingorani, S. R., Petricoin, E. F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M. A., Ross, S., Conrads, T. P., Veenstra, T. D., Hitt, B. A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00309-x · Cited by 2,471
NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis
Elinav, E., Strowig, T., Kau, A. L., Henao-Mejia, J., Thaiss, C. A., Booth, C. J., Peaper, D. R., Bertin, J., Eisenbarth, S. C., Gordon, J. I., et al. (2011) · Cell · doi:10.1016/j.cell.2011.04.022 · Cited by 2,024
The Epidemiology of Pancreatitis and Pancreatic Cancer
Yadav, D., & Lowenfels, A. B. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.01.068 · Cited by 1,974 · cited 1×
“1711 IntroductIon Pancreatic ductal adenocarcinoma (PDA) is a devastating disease in which the mortality rate approaches the incidence rate (Yadav and Lowenfels, 2013).”
BackgroundPancreatitis and the Risk of Pancreatic Cancer
Lowenfels, A. B., Maisonneuve, P., Cavallini, G., Ammann, R. W., Lankisch, P. G., Andersen, J. R., Dimagno, E. P., Andren-Sandberg, A., & Domellof, L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282001 · Cited by 1,757
Cited by
Diversity, Mechanisms, and Significance of Macrophage Plasticity
Locati, M., Curtale, G., & Mantovani, A. (2020) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012718 · Cited by 2,199
Pushalkar, S., Hundeyin, M., Daley, D., Zambirinis, C. P., Kurz, E., Mishra, A., Mohan, N., Aykut, B., Usyk, M., Torres, L. E., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-1134 · Cited by 1,400
Self-citationNLRP3 inflammasome in cancer and metabolic diseases
Sharma, B. R., & Kanneganti, T.-D. (2021) · Nature Immunology · doi:10.1038/s41590-021-00886-5 · Cited by 1,097
Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy
Gao, W., Wang, X., Zhou, Y., Wang, X., & Yu, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01046-3 · Cited by 1,042
Regulated cell death (RCD) in cancer: key pathways and targeted therapies
Peng, F., Liao, M., Qin, R., Zhu, S., Peng, C., Fu, L., Chen, Y., & Han, B. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01110-y · Cited by 832
Diverging inflammasome signals in tumorigenesis and potential targeting
Karki, R., & Kanneganti, T.-D. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0123-y · Cited by 641
Tumor microenvironment participates in metastasis of pancreatic cancer
Ren, B., Cui, M., Yang, G., Wang, H., Feng, M., You, L., & Zhao, Y. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0858-1 · Cited by 589
Gut Microbiota and Cancer: From Pathogenesis to Therapy
Vivarelli, S., Salemi, R., Candido, S., Falzone, L., Santagati, M., Stefani, S., Torino, F., Banna, G. L., Tonini, G., & Libra, M. (2019) · Cancers · doi:10.3390/cancers11010038 · Cited by 586
Immune modulatory effects of oncogenic KRAS in cancer
Hamarsheh, S., Groß, O., Brummer, T., & Zeiser, R. (2020) · Nature Communications · doi:10.1038/s41467-020-19288-6 · Cited by 387
Tumor Cell–Derived IL1β Promotes Desmoplasia and Immune Suppression in Pancreatic Cancer
Das, S., Shapiro, B., Vucic, E. A., Vogt, S., & Bar-Sagi, D. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-2080 · Cited by 366
Cell death in pancreatic cancer: from pathogenesis to therapy
Chen, X., Zeh, H. J., Kang, R., Kroemer, G., & Tang, D. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00486-6 · Cited by 336
Li, C., Zhang, Y., Cheng, X., Yuan, H., Zhu, S., Liu, J., Wen, Q., Xie, Y., Liu, J., Kroemer, G., et al. (2018) · Developmental Cell · doi:10.1016/j.devcel.2018.07.012 · Cited by 258
Harnessing innate immune pathways for therapeutic advancement in cancer
Hu, A., Sun, L., Lin, H., Liao, Y., Yang, H., & Mao, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01765-9 · Cited by 255
Pre-metastatic niche: formation, characteristics and therapeutic implication
Wang, Y., Jia, J., Wang, F., Fang, Y., Yang, Y., Zhou, Q., Yuan, W., Gu, X., Hu, J., & Yang, S. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01937-7 · Cited by 246
“176,177 An in vivo study revealed that tumor-secreted GRP78 interacts with hepatic DCs and macrophages within the metastatic niche, prompting the development of tolerogenic phenotypes.”
BackgroundRIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer
Wang, W., Marinis, J. M., Beal, A. M., Savadkar, S., Wu, Y., Khan, M., Taunk, P. S., Wu, N., Su, W., Wu, J., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.10.006 · Cited by 242
Self-citationMitophagy in tumorigenesis and metastasis
Poole, L. P., & Macleod, K. F. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03774-1 · Cited by 241
Inflammasomes and adaptive immune responses
Deets, K. A., & Vance, R. E. (2021) · Nature Immunology · doi:10.1038/s41590-021-00869-6 · Cited by 238
NLRP3 Inflammasome Activation in Cancer: A Double-Edged Sword
Hamarsheh, S., & Zeiser, R. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01444 · Cited by 230
Graziano, V., Dannhorn, A., Hulme, H., Williamson, K., Buckley, H., Karim, S. A., Wilson, M., Lee, S. Y., Kaistha, B. P., Islam, S., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-006457 · Cited by 213
Regulation and modulation of antitumor immunity in pancreatic cancer
Leinwand, J., & Miller, G. (2020) · Nature Immunology · doi:10.1038/s41590-020-0761-y · Cited by 206
Self-citationPyroptosis, a new bridge to tumor immunity
Li, L., Jiang, M., Qi, L., Wu, Y., Song, D., Gan, J., Li, Y., & Bai, Y. (2021) · Cancer Science · doi:10.1111/cas.15059 · Cited by 201
The Pancreatic Cancer Microenvironment
Dougan, S. K. (2017) · The Cancer Journal · doi:10.1097/ppo.0000000000000288 · Cited by 187
Ju, M., Bi, J., Wei, Q., Jiang, L., Guan, Q., Zhang, M., Song, X., Chen, T., Fan, J., Li, X., et al. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa345 · Cited by 185
“NLRP3 inflammasome was proved to influence maturation of NK cells by producing IL-18 to affect melanoma or colon carcinoma metastasis [13, 38].”
BackgroundInfluentialYang, Y., Li, S., To, K. K. W., Zhu, S., Wang, F., & Fu, L. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03377-9 · Cited by 184
The Hallmarks of Flavonoids in Cancer
Ponte, L. G. S., Pavan, I. C. B., Mancini, M. C. S., da Silva, L. G. S., Morelli, A. P., Severino, M. B., Bezerra, R. M. N., & Simabuco, F. M. (2021) · Molecules · doi:10.3390/molecules26072029 · Cited by 180
The promising role of tumor-associated macrophages in the treatment of cancer
Wang, H., Wang, X., Zhang, X., & Xu, W. (2024) · Drug Resistance Updates · doi:10.1016/j.drup.2023.101041 · Cited by 175
Inflammation in cancer: therapeutic opportunities from new insights
Xie, Y., Liu, F., Wu, Y., Zhu, Y., Jiang, Y., Wu, Q., Dong, Z., & Liu, K. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02243-8 · Cited by 167
Next frontier in tumor immunotherapy: macrophage-mediated immune evasion
Qiu, Y., Chen, T., Hu, R., Zhu, R., Li, C., Ruan, Y., Xie, X., & Li, Y. (2021) · Biomarker Research · doi:10.1186/s40364-021-00327-3 · Cited by 158
NF-κB: a double-edged sword controlling inflammation
Liu, D., Zhong, Z., & Karin, M. (2022) · Biomedicines · doi:10.3390/biomedicines10061250 · Cited by 157
Targeting ferroptosis in pancreatic cancer: a double-edged sword
Chen, X., Kang, R., Kroemer, G., & Tang, D. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.04.005 · Cited by 153
Mechanisms of NLRP3 priming in inflammaging and age related diseases
Gritsenko, A., Green, J., Brough, D., & López‐Castejón, G. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.08.003 · Cited by 153
Role of Mitochondria-Associated ER Membranes in Calcium Regulation in Cancer-Specific Settings
Morciano, G., Marchi, S., Morganti, C., Sbano, L., Bittremieux, M., Kerkhofs, M., Corricelli, M., Danese, A., Karkucińska‐Więckowska, A., Wieckowski, M. R., et al. (2018) · Neoplasia · doi:10.1016/j.neo.2018.03.005 · Cited by 143
Inflammasomes and Cancer: The Dynamic Role of the Inflammasome in Tumor Development
Kantono, M., & Guo, B. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01132 · Cited by 133
“PDA is also characterized with inflammatory and immunosuppressive tumor microenvironments (119–121).”
BackgroundInfluentialTargeting Innate Immunity in Cancer Therapy
Rameshbabu, S., Labadie, B. W., Argulian, A., & Patnaik, A. (2021) · Vaccines · doi:10.3390/vaccines9020138 · Cited by 129
Sun, J., Chen, F., & Wu, G. (2023) · The ISME Journal · doi:10.1038/s41396-023-01483-0 · Cited by 127
Ruze, R., Song, J., Yin, X., Chen, Y., Xu, R., Wang, C., & Zhao, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01376-w · Cited by 125
Zhang, L., Louie, A., Rigutto, G., Guo, H., Zhao, Y., Ahn, S., Dahlberg, S., Sholinbeck, M., & Smith, M. T. (2023) · Environmental Research · doi:10.1016/j.envres.2022.115188 · Cited by 106
NLRP3 inflammasome upregulates PD-L1 expression and contributes to immune suppression in lymphoma
Lu, F., Zhao, Y., Pang, Y., Ji, M., Sun, Y., Wang, H., Zou, J., Wang, Y., Li, G., Sun, T., et al. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.10.024 · Cited by 115
Dubey, S. R., Turnbull, C., Pandey, A., Zhao, A., Kurera, M., Al-Zidan, R. N., Shen, C. X., Gautam, M., Mahajan, S., Jadhav, P. S., et al. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01354-y · Cited by 115
Sethi, V., Vitiello, G. A., Saxena, D., Miller, G., & Dudeja, V. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.12.045 · Cited by 104
Self-citationPoh, A. R., & Ernst, M. (2021) · Cancers · doi:10.3390/cancers13122860 · Cited by 106
“NLRP3 signaling in macrophages drives the differentiation of CD4 T-cells into tumor-promoting Th2 cells, Th17 cells, and Tregs, while suppressing Th1 cell polarization and cytotoxic CD8 T-cell activation [102].”
BackgroundBrunetto, E., Monte, L. B. D., Balzano, G., Camisa, B., Laino, V., Riba, M., Heltai, S., Bianchi, M. E., Bordignon, C., Falconi, M., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0521-4 · Cited by 102
Targeting the NLRP3 Inflammasome as a New Therapeutic Option for Overcoming Cancer
Missiroli, S., Perrone, M., Boncompagni, C., Borghi, C., Campagnaro, A., Marchetti, F., Anania, G., Greco, P., Fiorica, F., Pinton, P., et al. (2021) · Cancers · doi:10.3390/cancers13102297 · Cited by 97
Liu, X., Xu, J., Zhang, B., Liu, J., Liang, C., Meng, Q., Hua, J., Yu, X., & Shi, S. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1117-9 · Cited by 83
Inflammasome inhibitors: promising therapeutic approaches against cancer
Xu, S., Li, X., Liu, Y., Xia, Y., Chang, R., & Zhang, C. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0755-0 · Cited by 86
IL-20 antagonist suppresses PD-L1 expression and prolongs survival in pancreatic cancer models
Lu, S.-W., Pan, H.-C., Hsu, Y., Chang, K., Wu, L., Chen, W., & Chang, M. (2020) · Nature Communications · doi:10.1038/s41467-020-18244-8 · Cited by 86
Lutz, V., Hellmund, V. M., Picard, F. S. R., Raifer, H., Ruckenbrod, T., Klein, M., Bopp, T., Savai, R., Duewell, P., Keber, C. U., et al. (2023) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-22-0398 · Cited by 86
Barilla, R., Diskin, B. E., Caso, R. C., Lee, K. B., Mohan, N., Buttar, C., Adam, S., Sekendiz, Z., Wang, J., Salas, R. D., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09416-2 · Cited by 86
Self-citationLuo, F., Li, H., Ma, W., Cao, J., Chen, Q., Lu, F., Qiu, M., Zhou, P., Xia, Z., Zeng, K., et al. (2023) · Cellular and Molecular Immunology · doi:10.1038/s41423-023-01112-y · Cited by 83
Pyroptosis: The missing puzzle among innate and adaptive immunity crosstalk
Hachim, M. Y., Khalil, B. A., Elemam, N. M., & Maghazachi, A. A. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mir0120-625r · Cited by 81
Role of the NLRP3 Inflammasome: Insights Into Cancer Hallmarks
Lin, T.-Y., Tsai, M.-C., Tu, W., Yeh, H., Wang, S., Huang, S., & Li, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.610492 · Cited by 80
Yu, C., Ding, Z., Liang, H., Zhang, B., & Chen, X. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00979 · Cited by 77
NLRP3 and cancer: Pathogenesis and therapeutic opportunities
Tengesdal, I. W., Dinarello, C. A., & Marchetti, C. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108545 · Cited by 78
The Multifaceted Roles of Pyroptotic Cell Death Pathways in Cancer
Wang, M., Jiang, S., Zhang, Y., Li, P., & Wang, K. (2019) · Cancers · doi:10.3390/cancers11091313 · Cited by 73
Upadhrasta, S., & Zheng, L. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091472 · Cited by 73
The role of interleukin-18 in pancreatitis and pancreatic cancer
Li, Z., Yu, X., Werner, J., Bazhin, A. V., & D’Haese, J. G. (2019) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2019.11.001 · Cited by 70
Interleukin-1 (IL-1) and the inflammasome in cancer
Prêtre, V., Papadopoulos, D., Regard, J. B., Pelletier, M. R., & Woo, J. (2022) · Cytokine · doi:10.1016/j.cyto.2022.155850 · Cited by 70
(2022) · doi:10.1016/j.hsr.2021.100010 · Cited by 69
Honda, T. S. B., Ku, J., & Anders, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1214289 · Cited by 66
Mechanisms Governing Immunotherapy Resistance in Pancreatic Ductal Adenocarcinoma
Schmiechen, Z. C., & Stromnes, I. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.613815 · Cited by 68
Friend or Foe? Recent Strategies to Target Myeloid Cells in Cancer
Chaib, M., Chauhan, S. C., & Makowski, L. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00351 · Cited by 67
Chronic Pancreatitis and the Development of Pancreatic Cancer
Kandikattu, H. K., Venkateshaiah, S. U., & Mishra, A. (2020) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530320666200423095700 · Cited by 63
Inflammasomes in Cancer Progression and Anti-Tumor Immunity
Lillo, S., & Saleh, M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.839041 · Cited by 62
Liang, M., Liu, Y., Zhang, Z., Yang, H., Dai, N., Zhang, N., Sun, W. Y., Guo, Y., Kong, J., Wang, X., et al. (2022) · Annals of Medicine · doi:10.1080/07853890.2022.2061045 · Cited by 60
Inflammasome Contribution to the Activation of Th1, Th2, and Th17 Immune Responses
Martynova, E. V., Rizvanov, A. A., Urbanowicz, R. A., & Khaiboullina, S. F. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.851835 · Cited by 59
Correlation Between the NLRP3 Inflammasome and the Prognosis of Patients With LSCC
Yi, X., Du, H.-D., Tang, D., Zhang, D., Zhou, J., Zhai, C., Yuan, C., Hsueh, C., Li, S., Heng, Y., et al. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00588 · Cited by 59
Inflammasomes: Emerging Central Players in Cancer Immunology and Immunotherapy
Karan, D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03028 · Cited by 58
Immunotherapy of pancreatic cancer
Sunami, Y., & Kleeff, J. H. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.03.006 · Cited by 57
Madamsetty, V. S., Pal, K., Keshavan, S., Caulfield, T. R., Dutta, S. K., Wang, E., Fadeel, B., & Mukhopadhyay, D. (2019) · Nanoscale · doi:10.1039/c9nr05478b · Cited by 56
Haloul, M., Oliveira, E., Kader, M., Wells, J. Z., Tominello, T. R., Andaloussi, A. E., Yates, C. C., & Ismail, N. (2019) · Scientific Reports · doi:10.1038/s41598-019-50320-y · Cited by 54
The Role of the Microbiome in Pancreatic Cancer
Miyabayashi, K., Ijichi, H., & Fujishiro, M. (2022) · Cancers · doi:10.3390/cancers14184479 · Cited by 53
NLRP3 inflammasome-induced pyroptosis in digestive system tumors
Wen, J., Xuan, B., Liu, Y., Wang, L., He, L., Meng, X., Zhou, T., & Wang, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1074606 · Cited by 53
Zhang, L., Li, H., Zang, Y., & Wang, F. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.9889 · Cited by 53
Tumor-intrinsic determinants of immunogenic cell death modalities
Workenhe, S. T., Pol, J. G., & Kroemer, G. (2021) · OncoImmunology · doi:10.1080/2162402x.2021.1893466 · Cited by 53
Inflammasomes cross-talk with lymphocytes to connect the innate and adaptive immune response
Zhang, H., Gao, J., Tang, Y., Jin, T., & Tao, J. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.01.012 · Cited by 52
Molecular mechanisms of pyroptosis and its role in anti-tumor immunity
Huang, H., Weng, Y., Tian, W., Lin, X., Chen, J., & Luo, L. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.86855 · Cited by 52
Dual Role of Inflammasome Adaptor ASC in Cancer
Protti, M. P., & Monte, L. B. D. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00040 · Cited by 52
Canonical and non-canonical functions of NLRP3
Accogli, T., Hibos, C., & Végran, F. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.01.001 · Cited by 51
Scarpitta, A., Hacker, U. T., Büning, H., Boyer, O., & Adriouch, S. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.731598 · Cited by 51
A Novel Classification Model for Lower-Grade Glioma Patients Based on Pyroptosis-Related Genes
Shen, Y., Chi, H., Xu, K., Li, Y., Yin, X., Chen, S., Yang, Q., He, M., Zhu, G., & Li, X. (2022) · Brain Sciences · doi:10.3390/brainsci12060700 · Cited by 49
Role of inflammasomes in cancer immunity: mechanisms and therapeutic potential
Singh, V. K., Ubaid, S., Kashif, M., Singh, T., Singh, G. P., Pahwa, R., & Singh, A. N. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03366-y · Cited by 46
Targeting SYK signaling in myeloid cells protects against liver fibrosis and hepatocarcinogenesis
Torres-Hernandez, A., Wang, W., Nikiforov, Y. E., Tejada, K., Torres, L. E., Kalabin, A., Wu, Y., Haq, M. I. U., Khan, M. Y., Zhao, Z., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0734-5 · Cited by 46
Self-citationYaw, A. C. K., Chan, E. W. L., Yap, J. K. Y., & Mai, C. (2020) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-020-03274-y · Cited by 45
Beyond the M‐ CSF receptor – novel therapeutic targets in tumor‐associated macrophages
Bonelli, S., Geeraerts, X., Bolli, E., Keirsse, J., Kiss, M., Antunes, A. R. P., Damme, H. V., Vlaminck, K. D., Movahedi, K., Laoui, D., et al. (2017) · FEBS Journal · doi:10.1111/febs.14202 · Cited by 42
Microbial Associations with Pancreatic Cancer: A New Frontier in Biomarkers
Stasiewicz, M., Kwaśniewski, M., & Karpiński, T. M. M. (2021) · Cancers · doi:10.3390/cancers13153784 · Cited by 42
Targeting Glycolysis in Macrophages Confers Protection Against Pancreatic Ductal Adenocarcinoma
Penny, H. L., Sieow, J. L., Gun, S. Y., Lau, M. C., Lee, B. T. K., Tan, J., Phua, C., Toh, F., Nga, Y., Yeap, W. H., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126350 · Cited by 40
NLRP3 inflammasome in digestive diseases: From mechanism to therapy
Qiang, R., Li, Y., Dai, X.-C., & Lv, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.978190 · Cited by 40
Liu, R., Li, J., Liu, L., Wang, W., & Jia, J. (2024) · Cancer Pathogenesis and Therapy · doi:10.1016/j.cpt.2024.07.004 · Cited by 39
Self-citationThe trigger for pancreatic disease: NLRP3 inflammasome
Liu, T., Wang, Q., Du, Z., Yin, L., Li, J., Meng, X., & Xue, D. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01550-7 · Cited by 39
An update on cell intrinsic negative regulators of the NLRP3 inflammasome
Poudel, B., & Gurung, P. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mir0917-350r · Cited by 38
Gastrointestinal microbiota and inflammasomes interplay in health and disease: a gut feeling
Luca, R. D., Arrè, V., Nardone, S., Incerpi, S., Giannelli, G., Trivedi, P., Anastasiadou, E., & Negro, R. (2025) · Gut · doi:10.1136/gutjnl-2025-334938 · Cited by 37
Regulation of dietary polyphenols on cancer cell pyroptosis and the tumor immune microenvironment
Huang, X., Wang, Y., Yang, W., Dong, J., & Li, L. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.974896 · Cited by 37
Intratumoral delivery of M-CSF by calcium crosslinked polymer micelles enhances cancer immunotherapy
Mao, K., Cong, X., Feng, L., Chen, H., Wang, J., Wu, C., Liu, K., Xiao, C., Yang, Y., & Sun, T. (2019) · Biomaterials Science · doi:10.1039/c9bm00226j · Cited by 37
Wu, H., Li, J., Yao, R., Liu, J., Su, L., & You, W. (2025) · Theranostics · doi:10.7150/thno.113727 · Cited by 36
Kleandrova, V. V., & Speck‐Planche, A. (2022) · Biomedicines · doi:10.3390/biomedicines10020491 · Cited by 36
Induction of pyroptotic cell death as a potential tool for cancer treatment
Faria, S. S., Fernando, A. J., de Lima, V. C. C., Rossi, A. G., de Carvalho, J. M. A., & Magalhães, K. G. (2022) · Journal of Inflammation · doi:10.1186/s12950-022-00316-9 · Cited by 36
Bastea, L. I., Liou, G., Pandey, V., Martinez, A. K. F., Roemeling, C. A. V., Döppler, H. R., Li, Z., Qiu, Y., Edenfield, B. H., Copland, J. A., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-1153 · Cited by 36
Chen, L., Wan, S., Mao, L., Huang, C., Bu, L., & Sun, Z. (2022) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-022-03357-4 · Cited by 35
Resolution of chronic inflammation and cancer
Tezcan, G., Yakar, N., Hastürk, H., Dyke, T. E. V., & Kantarcı, A. (2024) · Periodontology 2000 · doi:10.1111/prd.12603 · Cited by 34
Role of NLRP3 inflammasome in systemic sclerosis
Lin, C., Jiang, Z., Cao, L., Zou, H., & Zhu, X. (2022) · Arthritis Research & Therapy · doi:10.1186/s13075-022-02889-5 · Cited by 34
Metadata
- Authors
- Daley, D., Mani, V. R., Mohan, N., Akkad, N., Pandian, G. S. D. B., Savadkar, S., Lee, K. B., Torres-Hernandez, A., Aykut, B., Diskin, B., Wang, W., Farooq, M. S., Mahmud, A. I., Werba, G., Morales, E. J., Lall, S., Wadowski, B. J., Rubin, A. G., Berman, M. E., Narayanan, R., Hundeyin, M., & Miller, G.
- Affiliations
- New York University (US)
- S.A. Localio Laboratory, Department of Surgery, New York University School of Medicine, New York, NY 10016 1
- Corresponding author
- Miller, George
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2017-04-25
- Volume
- 214
- Issue
- 6
- Pages
- 1711-1724
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC5461004
- OpenAlex
- W2608757343
- Cited by
- 244
- References
- 49
- Citations by year
- 2026: 11 · 2025: 28 · 2024: 24 · 2023: 44 · 2022: 42 · 2021: 29 · 2020: 22 · 2019: 28 · 2018: 12 · 2017: 4
- FWCI
- 8.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Experimental Medicine (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (CA168611, CA155649, CA206105)
- Department of Defense
- Lustgarten Foundation
- American Association for Cancer Research
- Pancreatic Cancer Action Network
- Hirshberg Foundation for Pancreatic Cancer Research
- Irene and Bernard Schwartz Fellowship in Gastrointestinal Oncology
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- NLRP3 inflammasome, pancreatic ductal adenocarcinoma, tumor microenvironment, tumor-associated macrophages, IL-10, Th17 cells, regulatory T cells, Th2 cells, CD8+ T cell activation, ASC, caspase-1, immunotherapy, macrophage reprogramming
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Cell Differentiation, Humans, Immunosuppression Therapy, Macrophages, Mice, Inbred C57BL, Pancreatic Neoplasms, T-Lymphocytes, Signal Transduction, Gene Deletion, Caspase 1, Carcinoma, Pancreatic Ductal, Cell Proliferation, Apoptosis Regulatory Proteins, CARD Signaling Adaptor Proteins, Nod2 Signaling Adaptor Protein, Adaptive Immunity, Pancreatic Stellate Cells, Tumor Microenvironment, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.